Sermonix Pharmaceuticals Closes $40 Million Series A3 Financing Round Led by Perceptive Xontogeny Ventures Fund II

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3qLROaR
via IFTTT